Skip to main content

Peer Review reports

From: Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity

Original Submission
28 Nov 2022 Submitted Original manuscript
2 Feb 2023 Reviewed Reviewer Report
19 Feb 2023 Reviewed Reviewer Report
10 Mar 2023 Reviewed Reviewer Report
7 Apr 2023 Author responded Author comments - Bowen Wu
18 Apr 2023 Author responded Author comments - Bowen Wu
Resubmission - Version 2
7 Apr 2023 Submitted Manuscript version 2
9 May 2023 Author responded Author comments - Bowen Wu
Resubmission - Version 3
9 May 2023 Submitted Manuscript version 3
23 May 2023 Author responded Author comments - Bowen Wu
Resubmission - Version 4
23 May 2023 Submitted Manuscript version 4
Publishing
2 Sep 2023 Editorially accepted
12 Oct 2023 Article published 10.1186/s40360-023-00685-8

You can find further information about peer review here.

Back to article page